Press-release for stocks in the health technology sector

Prices are updated after-hours

sector : Health technology crawled time : 14:00

save search

GL Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Globe Life Inc. (GL) Investors to Contact the Firm
Published: 2024-04-19 (Crawled : 14:00) - prnewswire.com
ZTS | News | $146.5 -4.32% 0.0% 6.2M

Health Technology

| 0.0% | O: 0.09% H: 0.0% C: 0.0%
GL | News | $66.74 2.68% 0.03% 3.1M

Finance

| 0.0% | O: 2.67% H: 3.36% C: 1.96%
life

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectati...
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| 0.0% | O: 0.83% H: 1.35% C: 1.2%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
miss

Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
OM | News | $2.33 3.56% 3.43% 830K

Health Technology

| 0.0% | O: 3.24% H: 6.28% C: 4.04%
first report medical financial results

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
Published: 2024-04-18 (Crawled : 14:00) - globenewswire.com
GRFS | News | $6.29 -3.82% -3.97% 1.2M

Health Technology

| -0.61% | O: 0.91% H: 0.0% C: -1.51%
for

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| 0.12% | O: 0.12% H: 0.0% C: 0.0%
fda biosimilar approval for stelara

Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
OM | News | $2.33 3.56% 3.43% 830K

Health Technology

| 3.85% | O: 3.85% H: 6.94% C: 0.0%
multi-year renal care dialysis medical home agreement

Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M

Health Technology

| 0.87% | O: 1.22% H: 0.21% C: -0.34%
vent-02 trial therapeutics results

Biopharma Layoff Tracker 2024: Fujifilm, Genentech, Sanofi and More Cut Staff
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
RLYB | News | $1.75 4.79% 4.57% 310K

| -5.0% | O: -4.44% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -0.08% | O: -0.04% H: 0.28% C: -0.16%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M

Health Technology

| -2.73% | O: -0.49% H: 2.25% C: -2.25%
TXMD | News | $1.86 -1.59% -1.61% 10K

Health Technology

| -0.53% | O: 2.63% H: 3.59% C: -3.08%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -0.78% | O: 1.05% H: 0.0% C: 0.0%
PTCT | News S | $25.32 2.55% 2.49% 3.9M

Health Technology

| -0.51% | O: 0.83% H: 0.0% C: -1.33%
NKTR | News | $1.265 -4.17% -4.35% 4.7M

Health Technology

| -9.4% | O: -0.67% H: 1.35% C: -8.78%
MOR | News | $17.96 -0.5% -0.5% 180K

Health Technology

| 0.56% | O: 0.17% H: 0.39% C: 0.33%
GLPG | News | $29.095 0.64% 0.64% 87K

Health Technology

| -0.92% | O: -0.14% H: 0.17% C: -0.78%
AMRN | News | $0.88 0.94% 0.93% 1M

Health Technology

| 3.69% | O: 3.69% H: 0.0% C: 0.0%
GOOGL | News S | $154.08 -1.24% -1.25% 32M

Technology Services

| 0.83% | O: 1.03% H: 0.94% C: -0.1%
GOOG | News S | $155.7 -1.12% -1.13% 20M

Technology Services

| 0.79% | O: 0.97% H: 0.95% C: -0.2%
OCX | News J | $2.495 -2.54% -2.61% 50K

Health Technology

| -5.82% | O: -0.36% H: 0.0% C: -5.47%
biopharma sanofi

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -0.08% | O: -0.04% H: 0.28% C: -0.16%
XOMA | News | $24.97 1.55% 1.52% 17K

Health Technology

| -0.53% | O: -1.48% H: 1.08% C: 0.96%
biopharma platform

Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
ESTA | $47.425 -9.79% -10.85% 430K

Health Technology

| 0.79% | O: 0.79% H: 0.0% C: 0.0%
aesthetic meeting

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVRO | $12.07 -2.03% 0.0% 390K

Health Technology

| -3.23% | O: -0.55% H: 0.16% C: -2.69%
conference report financial results

Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AMRX | $5.42 1.12% 1.11% 1.1M

Health Technology

| -3.25% | O: -1.08% H: 1.09% C: -0.55%
rtu first

VBI Vaccines Reports Full Year 2023 Financial Results
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VBIV | $0.6396 1.57% 1.55% 160K

Health Technology

| 8.62% | O: -3.45% H: 14.29% C: 10.71%
year financial results

J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology